Literature DB >> 8952708

Fenvalerate-induced alterations in circulatory thyroid hormones and calcium stores in rat brain.

P P Kaul1, A Rastogi, R K Hans, T D Seth, P K Seth, R C Srimal.   

Abstract

Intraperitoneal administration of fenvalerate, a synthetic pyrethroid, in male rats for 45 days in doses of 100 and 200 mg/kg body weight/day induced hyperexcitability, tremors and paralysis. Tremors were observed after 7 days and gradually reached maxima on 45th day. The symptoms were more marked in rats treated with 200 mg/kg body weight/day. Fenvalerate provoked significant elevation of circulatory thyroid hormones, namely tri-iodothyronine (T3) and thyroxine (T4). A significant increase in total calcium as well as protein-bound calcium in whole brain and hypothalamus were recorded. The elevation of circulatory thyroid hormones as well as the active calcium pool could be together responsible for impairment of motor activity by altering various neuronal processes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8952708     DOI: 10.1016/s0378-4274(96)03778-2

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  4 in total

1.  Pyrethroid insecticide metabolites are associated with serum hormone levels in adult men.

Authors:  John D Meeker; Dana B Barr; Russ Hauser
Journal:  Reprod Toxicol       Date:  2009-01-24       Impact factor: 3.143

2.  Estrogenic potential of certain pyrethroid compounds in the MCF-7 human breast carcinoma cell line.

Authors:  V Go; J Garey; M S Wolff; B G Pogo
Journal:  Environ Health Perspect       Date:  1999-03       Impact factor: 9.031

Review 3.  Thyroid-disrupting chemicals and brain development: an update.

Authors:  Bilal B Mughal; Jean-Baptiste Fini; Barbara A Demeneix
Journal:  Endocr Connect       Date:  2018-03-23       Impact factor: 3.335

Review 4.  Pesticides With Potential Thyroid Hormone-Disrupting Effects: A Review of Recent Data.

Authors:  Michelle Leemans; Stephan Couderq; Barbara Demeneix; Jean-Baptiste Fini
Journal:  Front Endocrinol (Lausanne)       Date:  2019-12-09       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.